Search results
Results from the WOW.Com Content Network
Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, which they have dubbed “post-vaccination syndrome."
“The most common cause of vaginal odor is an imbalance in the normal flora in the vagina,” which causes a fishy odor, irritation, and thin to no vaginal discharge, says Dr. Streicher.
What experts want you to know: “A vinegar or garlic-like vaginal odor is usually nothing to worry about, unless the smell is extremely strong or you’re feeling uncomfortable; if so, I ...
The specific use of the term "vaccine shedding" has risen to public prominence through anti-vaccine activists linked to misinformation related to COVID-19, who erroneously claim that COVID-19 vaccination can cause individuals to shed coronavirus spike protein and affect menstruation and fertility in women exposed to them.
The thrombosis events associated with the COVID‑19 vaccine may occur 4–28 days after its administration and mainly affects women under 55. [6] [2] [20] Several relatively unusual types of thrombosis were specifically reported to be occurring in those with the reaction: cerebral venous sinus thrombosis and thrombosis of the splanchnic veins.
A study in Andrologia found that Google searches relating to a supposed link between vaccination against COVID-19 and adverse effects on fertility increased following the Emergency Use Authorization of COVID vaccines in the United States, indicating that concerns about alleged impacts on fertility are a major contributor to vaccine hesitancy. [39]
The updated COVID-19 vaccine is now available. Infectious disease doctors recommend being smart about the timing of your shot. You can expect similar side effects to the previous vaccines if you ...
In February 2021, data released from an interim analysis of Phase III trials with 30,000 participants and 101 COVID cases showed that globally, the vaccine administered as an intramuscular injection had an efficacy of 65.7% at preventing moderate cases of COVID-19 and 90.98% efficacy at preventing severe cases. In the Pakistan trial subset, the ...